पोस्ट करनेवाले : boarder77
| Price when posted : BSE: Rs 442.25 ( -2.78 % ), NSE: Rs. 442.05 ( -2.86 % )|
Just wanted to add that research costs may not see a step function rise in Q4 and margins may stay protect with slight upward bias. Very soon Malaysia facility will start grabbing media and analyst attention and then these valuations will look reasonable / under valued. The only concern perhaps is that of changing market mood where Tom, Dick and Debt-mal have started moving north and hot money will invariably chase the rising tide - Biocon will likely underperform in the run up to the elections. What happens in late May / early June is anybody`s guess but here are some scenarios
BJP led Govt in Power - Rupee appreciates and Biocon along with larget IT and Pharma pack feels the pain
Left and others make a less stable govt - then we go back to the Q4 2013 scenario where IT and Pharma roar once again...